Jornalwebdigital: Biomea Fusion

Mostrando postagens com marcador Biomea Fusion. Mostrar todas as postagens

Biomea Fusion Announces First Patient Dosed in Phase I Study of BMF-650 a Next-Generation Oral GLP-1 Receptor Agonist

SAN CARLOS, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion” or the “Company”) (Nasdaq: BMEA), a cli...Leia Mais

Biomea Fusion

Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series

Redação 21.10.25

SAN CARLOS, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity c...Leia Mais